These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23970161)

  • 41. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
    Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
    Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation regulation of liver-specific microRNA-122 expression and its effects on the proliferation and apoptosis of hepatocellular carcinoma cells.
    Xing TJ; Xu HT; Yu WQ; Jiang DF
    Genet Mol Res; 2013 Sep; 12(3):3588-97. PubMed ID: 24085423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma.
    Jin W; Lee JJ; Kim MS; Son BH; Cho YK; Kim HP
    Biochem Biophys Res Commun; 2011 Mar; 406(1):89-95. PubMed ID: 21295543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A natural antisense transcript regulates acetylcholinesterase gene expression via epigenetic modification in Hepatocellular Carcinoma.
    Xi Q; Gao N; Zhang X; Zhang B; Ye W; Wu J; Zhang X
    Int J Biochem Cell Biol; 2014 Oct; 55():242-51. PubMed ID: 25240585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
    Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
    Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
    He Y; Cui Y; Xu B; Gu J; Wang W; Luo X
    PLoS One; 2014; 9(1):e87994. PubMed ID: 24498236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Research progress in tumor-suppressor gene methylation of hepatocellular carcinoma].
    Dai H; Liu NZ; Zuo GQ
    Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):143-6. PubMed ID: 23847928
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.
    Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
    Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoter methylation assay of SASH1 gene in hepatocellular carcinoma.
    Peng L; Wei H; Liren L
    J BUON; 2014; 19(4):1041-7. PubMed ID: 25536614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.
    Lv J; Zhu P; Zhang X; Zhang L; Chen X; Lu F; Yu Z; Liu S
    Mol Med Rep; 2017 Oct; 16(4):4475-4482. PubMed ID: 28791409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delta-like 3 is silenced by methylation and induces apoptosis in human hepatocellular carcinoma.
    Maemura K; Yoshikawa H; Yokoyama K; Ueno T; Kurose H; Uchiyama K; Otsuki Y
    Int J Oncol; 2013 Mar; 42(3):817-22. PubMed ID: 23337976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation.
    Ghoshal K; Majumder S; Li Z; Dong X; Jacob ST
    J Biol Chem; 2000 Jan; 275(1):539-47. PubMed ID: 10617649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
    Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
    Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the Nonstructural Protein-Nucleolar and Coiled-Body Phosphoprotein 1 Protein Interaction on rRNA Synthesis Through Telomeric Repeat-Binding Factor 2 Regulation Under Nucleolar Stress.
    Zhang M; Zeng Y; Wang F; Feng H; Liu Q; Li F; Zhao S; Zhao J; Liu Z; Zheng F; Liu H
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):408-416. PubMed ID: 38062753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
    Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
    PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.